References of "FRANCHIMONT, Claudine"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailLa dermocosmétique en appui de traitements oncologiques ciblés.
FRANCHIMONT, Claudine ULg; Lesuisse, Marianne; PIERARD, Gérald ULg

in Revue Médicale de Liège (2014), 69(1), 35-37

Some recently introduced targeted treatments in cancerology are responsible for adverse effects on the skin. These events alter the patient well-being. Adequate dermocosmetic management allows to curb the ... [more ▼]

Some recently introduced targeted treatments in cancerology are responsible for adverse effects on the skin. These events alter the patient well-being. Adequate dermocosmetic management allows to curb the unwanted skin conditions without interfering with the targeted therapeutic effects. However, evidence-based support for using dermocosmetic products as adjunctive cancer treatment remains scarce. It remains nonetheless that the clinical perception is unanimously favourable for such procedure. [less ▲]

Detailed reference viewed: 14 (1 ULg)
Full Text
See detailHand dermometrology
PIERARD, Gérald ULg; Pierard, Sébastien ULg; Franchimont, Claudine ULg et al

in Alikhan, A.; Lachapelle, J.M.; Maibach, M.I. (Eds.) Textbook of hand eczema. (2014)

Detailed reference viewed: 15 (0 ULg)
Peer Reviewed
See detailHedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
FRANCHIMONT, Claudine ULg; Hermanns-Lê, Trinh ULg; PAQUET, Philippe ULg et al

in Current approaches to basal cell carcinoma (2014)

Basal cell carcinomas (BCCs) are the most frequent human cancer. Over 90% of all BCCs have a mutation in patched homologue 1 (PTCH 1) or smoothened (SMO), two conducting proteins of the Hedgehog (Hh ... [more ▼]

Basal cell carcinomas (BCCs) are the most frequent human cancer. Over 90% of all BCCs have a mutation in patched homologue 1 (PTCH 1) or smoothened (SMO), two conducting proteins of the Hedgehog (Hh) pathway. They rarely progress deeply and metastasize; however, if they do, these advanced BCC become amenable to treatment by inhibiting the Hedgehog and the P13K–mTOR pathways. Such innovative drugs include vismodegib, cyclopamine, itraconazole, everolimus and a few other agents that are in early clinical development. [less ▲]

Detailed reference viewed: 82 (9 ULg)
Full Text
Peer Reviewed
See detailNail surface topography and onychochronobiology.
PIERARD, Gérald ULg; Franchimont, Claudine ULg

in Berardesca, E.; Wilhelm, K.P.; Maibach, H.I. (Eds.) Non invasive diagnostic techniques in clinical dermatology. (2014)

Detailed reference viewed: 24 (8 ULg)
Full Text
Peer Reviewed
See detailCorneosurfametry and corneoxenometry.
PIERARD, Gérald ULg; Franchimont, Claudine ULg; REGINSTER, Marie-Annick ULg

in Berardesca, Enzo; Wilhelm, K.P.; Maibach, H.I. (Eds.) Non invasive diagnostic techniques in clinical dermatology. (2014)

Detailed reference viewed: 23 (7 ULg)
Full Text
Peer Reviewed
See detailCyanoacrylate skin surface / follicular stripping.
PIERARD, Gérald ULg; Franchimont, Claudine ULg; Delvenne, Philippe ULg et al

in Berardesca, Enzo; Wilhelm, KP; Maibach, H.I. (Eds.) Non invasive diagnostic techniques in clinical dermatology. (2014)

Detailed reference viewed: 30 (14 ULg)
Full Text
Peer Reviewed
See detailVisioscan-driven ULEV method.
PIERARD, Gérald ULg; Franchimont, Claudine ULg; Pierard, Sébastien ULg

in Berardesca, Enzo (Ed.) Non invasive diagnostic techniques in clinical dermatology. (2014)

Detailed reference viewed: 12 (1 ULg)
Full Text
Peer Reviewed
See detailLa cascade des MAP kinases : traitements ciblés en cancérologie cutanée.
PIERARD, Gérald ULg; Franchimont, Claudine ULg; LEONARD, Boris ULg et al

in Revue Médicale de Liège (2013), 68(12), 650-654

Résumé : Les «Mitogen-Activated Protein Kinases» (MAPK) forment un ensemble coordonné de protéines cellulaires impliquées dans la prolifération, la différenciation, la migration et l’apoptose des cellules ... [more ▼]

Résumé : Les «Mitogen-Activated Protein Kinases» (MAPK) forment un ensemble coordonné de protéines cellulaires impliquées dans la prolifération, la différenciation, la migration et l’apoptose des cellules. Elles sont particulièrement activées, par certaines cytokines, hormones, le stress environnemental, ainsi que dans des cancers cutanés. Des agents pharmacologiques ciblés contre la cascade MAPK révolutionnent actuellement la cancérologie cutanée, du moins dans une phase transitoire du processus métastatique. Des traitements combinés sont susceptibles d’améliorer la survie médiane. [less ▲]

Detailed reference viewed: 8 (4 ULg)
Full Text
Peer Reviewed
See detailDermal ultrastructure in collagen VI myopathy.
Hermanns-Lê, Trinh ULg; PIERARD, Gérald ULg; Franchimont, Claudine ULg et al

in Ultrastructural Pathology (2013)

Detailed reference viewed: 33 (2 ULg)
Full Text
Peer Reviewed
See detailEhlers-Danlos syndrome.
Hermanns-Lê, Trinh ULg; REGINSTER, Marie-Annick ULg; Franchimont, Claudine ULg et al

in Stirling, J; Curry, A; Eyden, B (Eds.) Diagnostic electron microscopy (2013)

Detailed reference viewed: 50 (7 ULg)
Full Text
Peer Reviewed
See detailRevisiting the cutaneous impact of oral hormone replacement therapy.
PIERARD, Gérald ULg; Humbert, Philippe; Berardesca, Enzo et al

in BioMed Research International (2013), 2013(971760),

Detailed reference viewed: 12 (2 ULg)
Full Text
Peer Reviewed
See detailLa vignette diagnostique de l'etudiant. Le spectre des toxidermies.
Hermanns-Lê, Trinh ULg; Franchimont, Claudine ULg; PIERARD, Gérald ULg

in Revue Médicale de Liège (2013), 68(1), 44-50

Drug eruptions are frequently encountered and they represent "diseases of medical progress". They are expected in about 2% of treated patients. Their putative diagnosis is based on a set of imputability ... [more ▼]

Drug eruptions are frequently encountered and they represent "diseases of medical progress". They are expected in about 2% of treated patients. Their putative diagnosis is based on a set of imputability factors. Several distinct drug-induced skin disorders are identified. They are initially recognized from personal experience, but the implication to a specific drug derives from the collective experience of published evidence. Their histopathological aspect is often evocative or demonstrative for the nature of the dermatosis. Some drug eruptions follow an indolent course, while others are life-threatening. [less ▲]

Detailed reference viewed: 13 (3 ULg)
Full Text
Peer Reviewed
See detailL'addiction au Soleil, son estocade et la parade des crèmes solaires.
FRANCHIMONT, Claudine ULg; Hermanns-Lê, Trinh ULg; PIERARD, Gérald ULg et al

in Revue Médicale de Liège (2013), 68(5-6), 321-325

Detailed reference viewed: 22 (3 ULg)
Full Text
Peer Reviewed
See detailThe skin landscape in diabetes mellitus. Focus on dermocosmetic management.
PIERARD, Gérald ULg; Seite, Sophie; Hermanns-Lê, Trinh ULg et al

in Clinical, Cosmetic and Investigational Dermatology (2013), 6

BACKGROUND: Some relationships are established between diabetes mellitus (DM) and a series of cutaneous disorders. Specific dermatoses are markers for undiagnosed DM. Other disorders represent supervening ... [more ▼]

BACKGROUND: Some relationships are established between diabetes mellitus (DM) and a series of cutaneous disorders. Specific dermatoses are markers for undiagnosed DM. Other disorders represent supervening complications in an already treated DM patient. OBJECTIVE: To review the information about dermocosmetic care products and their appropriate use in the management and prevention of dermatoses related to DM. METHOD: The peer-reviewed literature and empiric findings are covered. Owing to the limited clinical evidence available for the use of dermocosmetics, a review of the routine practices and common therapies in DM-related dermatoses was conducted. RESULTS: Some DM-related dermatoses (acanthosis nigricans, pigmented purpuric dermatosis) are markers of macrovascular complications. The same disorders and some others (xerosis, Dupuytren's disease) have been found to be more frequently associated with microangiopathy. Other skin diseases (alopecia areata, vitiligo) were found to be markers of autoimmunity, particularly in type 1 DM. Unsurprisingly, using dermocosmetics and appropriate skin care has shown objective improvements of some DM-related dermatoses, such effects improve the quality of life. The most common skin manifestations of DM fall along continuum between "dry skin," xerosis, and acquired ichthyosis, occurring predominately on the shins and feet. Dermocosmetic products improve the feeling of well-being for DM patients. [less ▲]

Detailed reference viewed: 25 (3 ULg)
Full Text
Peer Reviewed
See detailComment j'explore ... l'atteinte fonctionnelle cutanee d'une sclerodermie.
Hermanns-Lê, Trinh ULg; Franchimont, Claudine ULg; PIERARD, Gérald ULg et al

in Revue Médicale de Liège (2013), 68(3), 141-7

Scleroderma refers to distinct clinical presentations sharing in common a sclerotic process most often clinically obvious on the skin. The involvement possibly affects the skin alone in morphea or in ... [more ▼]

Scleroderma refers to distinct clinical presentations sharing in common a sclerotic process most often clinically obvious on the skin. The involvement possibly affects the skin alone in morphea or in combination with internal lesions in systemic sclerosis. Some objective and non-invasive functional assessments are useful for better appreciating the severity and evolution of the disease, as well as to monitor the therapeutic efficacy. In this endeavour, in vivo measurements of the skin mechanical properties are unsurprisingly informative. [less ▲]

Detailed reference viewed: 26 (11 ULg)
Full Text
Peer Reviewed
See detailScleroderma: skin stiffness assessment using the stress-strain relationship under progressive suction.
PIERARD, Gérald ULg; Hermanns-Lê, Trinh ULg; Franchimont, Claudine ULg

in Expert Opinion on Medical Diagnostics (2013), 7(2), 119-25

Introduction: A few non-invasive biometrological methods are available for monitoring skin stiffening in systemic scleroderma. Among them, the Cutometer(R) is used for years by several clinical teams ... [more ▼]

Introduction: A few non-invasive biometrological methods are available for monitoring skin stiffening in systemic scleroderma. Among them, the Cutometer(R) is used for years by several clinical teams. Objectives: To revisit the microscopic structure of the dermal fibrous networks in scleroderma and the relationship with changes in viscoelasticity. Methods: The suction method delivered by the Cutometer(R) was applied following the progressive stress-vs-strain modality. Results: The test procedure was sensitive enough to document the initial progression steps of acroscleroderma. Four stages were thus identified including i) the incipient, ii) the progressive, iii) the overt, and iv) the regressive acroscleroderma. Conclusion: The non-invasive determination of skin biomechanical functions is relevant both in routine clinical practice and in antisclerotic drug development. It is complementary although not a substitute for the determination of selected serum biomarkers. [less ▲]

Detailed reference viewed: 35 (8 ULg)
Full Text
Peer Reviewed
See detailAlterations in hair follicle dynamics in women.
Franchimont, Claudine ULg; PIERARD, Gérald ULg

in BioMed Research International (2013), 2013(957432),

Detailed reference viewed: 23 (9 ULg)